We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

45 hedge funds and large institutions have $88.4M invested in Neos Therapeutics, Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 8

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

5% more funds holding

Funds holding: 4345 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

30% less capital invested

Capital invested by funds: $127M → $88.4M (-$38.5M)

Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
11
Increased
18
Reduced
8
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$229K
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$226K
NC
28
Nexthera Capital
New York
$215K +$226K +15,000 New
Deutsche Bank
29
Deutsche Bank
Germany
$199K +$212K +14,033 New
ProShare Advisors
30
ProShare Advisors
Maryland
$195K +$205K +13,623 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$146K +$1.51K +100 +1%
BAMCO Inc
32
BAMCO Inc
New York
$143K -$477K -31,600 -76%
TA
33
Teachers Advisors
New York
$81K
Citigroup
34
Citigroup
New York
$77K +$78.4K +5,195 +3,440%
Morgan Stanley
35
Morgan Stanley
New York
$69K +$21.2K +1,403 +41%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$53K +$55.8K +3,700 New
UBS Group
37
UBS Group
Switzerland
$51K -$11.5K -760 -18%
NFA
38
Nationwide Fund Advisors
Ohio
$46K +$32.1K +2,129 +191%
Bank of America
39
Bank of America
North Carolina
$39K +$40.6K +2,692 New
SO
40
STRS Ohio
Ohio
$25K
BA
41
BlackRock Advisors
Delaware
$17K -$15.2K -1,010 -46%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$14.2K -$452 -30 -3%
CCA
43
Catalyst Capital Advisors
New York
$3K +$3.09K +205 New
Barclays
44
Barclays
United Kingdom
$3K +$4K +265 New
TCP
45
Tourbillon Capital Partners
New York
-$12.9M -611,686 Closed
CS
46
Credit Suisse
Switzerland
-$2.59M -123,305 Closed
WRF
47
Waddell & Reed Financial
Kansas
-$840K -40,000 Closed
Millennium Management
48
Millennium Management
New York
-$286K -13,628 Closed
Goldman Sachs
49
Goldman Sachs
New York
-$227K -10,820 Closed
Norges Bank
50
Norges Bank
Norway
-$204K -9,700 Closed

NEOS Hedge Fund Activity: Q4 2015 in Review

45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2015, worth a combined $88.4M — down 30% from $127M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NEOS positions and 9 closed out — a net gain of 2 holders — while 18 added to existing stakes and 8 trimmed.

The largest buyer was Franklin Resources, adding an estimated $5.49M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $12.9M sold.

  • 45 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2015, up from 43 in Q3 2015.
  • Funds reported $88.4M of Neos Therapeutics, Inc stock for Q4 2015, down 30% quarter-over-quarter.
  • 11 funds opened new Neos Therapeutics, Inc positions in Q4 2015 and 9 closed out, a net change of +2 holders.
  • The largest Neos Therapeutics, Inc buyer in Q4 2015 was Franklin Resources, an estimated $5.49M added.
  • The largest Neos Therapeutics, Inc seller in Q4 2015 was Tourbillon Capital Partners, an estimated $12.9M sold.

Based on aggregated 13F filings for Q4 2015.